Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 08.10.2025 | Arthrosi T... | arthrosi.com | $228M | United Sta... |
Mentions in press and media 12
| Date | Title | Description |
| 14.04.2026 | Deals in brief: Three Singapore startups raise AI funding; SC Ventures leads Keyrock’s Series C round; six China investments; and more | Muun AI raises USD 700,000 from Wavemaker Impact Muun AI, a Singapore-based startup, has raised USD 700,000 in a pre-seed funding round from Wavemaker Impact. The startup develops industrial intelligence systems that convert machine telemet... |
| 13.04.2026 | Vivatides Therapeutics Raises $54M in Series A Funding | Vivatides Therapeutics, a Suzhou, China- and Boston, MA-based biotechnology company focused on developing extrahepatic RNA-targeting therapeutics, raised $54M in Series A funding. The round was co-led by Qiming Venture Partners, with partic... |
| 15.10.2025 | Arthrosi Secures $153 Million to Accelerate Gout Treatment | Arthrosi Therapeutics recently closed a significant $153 million Series E funding round. This vital capital directly supports late-stage clinical development of pozdeutinurad, a promising next-generation URAT1 inhibitor. The San Diego-based... |
| 14.10.2025 | Arthrosi: $153 Million Series E Raised For Developing Gout Treatments | Arthrosi Therapeutics has closed a $153 million Series E funding round. This late-stage biotechnology company is focused on developing a next-generation URAT1 inhibitor, which has the potential to be a best-in-class treatment for patients s... |
| 08.10.2025 | Arthrosi Raises $153M in Series E Funding | Arthrosi, a San Diego, CA-based late-stage biotechnology company developing URAT1 inhibitors, raised $153M in Series E funding. The round was led by Prime Eight Capital Limited and with participation from CR Biotech, HighLight Capital, HM V... |
| 17.09.2025 | RobStride builds the joints that keep China’s robots moving, and a thriving industry around them | RobStride Dynamics, founded in November 2023, is carving out a niche in integrated joint modules. In less than two years, it has supplied nearly half of embodied intelligence companies in China. The company is led by Wang Bo, an automation ... |
| 10.07.2025 | HighLight Capital joins global investors in backing NUCLIDIUM | - |
| 28.05.2025 | To develop novel therapies for cardiomyopathy, Nuevocor raised $45 M Series B funding | The Singapore-based IND-stage biotechnology startup Nuevocor, which is working to find treatments for cardiomyopathies caused by aberrant mechanobiology, has successfully closed a $45 million Series B funding round. Nuevocor said in a state... |
| 01.04.2025 | Aramco's Prosperity7 leads $73m financing in China's Spirit AI | Prosperity7 Ventures, a venture capital (VC) fund of Saudi oil giant Aramco, has led a Series Pre-A funding round of 528 million yuan ($72.8 million) in China’s Spirit AI amid a frenzy of early-stage financing in embodied intelligence. Spir... |
| 24.02.2025 | Healthcare focus drives HighLight Capital’s exits amid market downturn | At a time when most fund managers are grappling with a liquidity crunch, Shanghai-based HighLight Capital managed to score several exits and return capital to its investors last year. |
Show more